scispace - formally typeset
Open AccessJournal ArticleDOI

Insulin resistance: A metabolic pathway to chronic liver disease†

TLDR
The ability of insulin‐sensitizing, pharmacological agents to treat NAFLD by reducing IR in the liver (metformin) and in the periphery (thiazolidinediones) are discussed.
About
This article is published in Hepatology.The article was published on 2005-11-01 and is currently open access. It has received 804 citations till now. The article focuses on the topics: Nonalcoholic fatty liver disease & Liver disease.

read more

Citations
More filters
Journal ArticleDOI

Mechanisms of NAFLD development and therapeutic strategies

TL;DR: Understanding of pathogenic mechanisms and clinical features of NAFLD is driving progress in therapeutic strategies now in clinical trials and the emerging targets for drug development that involve either single agents or combination therapies intended to arrest or reverse disease progression are discussed.
Journal ArticleDOI

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

TL;DR: FLI is simple to obtain and may help physicians select subjects for liver ultrasonography and intensified lifestyle counseling, and researchers to select patients for epidemiologic studies, but validation of FLI in external populations is needed before it can be employed for these purposes.
Journal ArticleDOI

A position statement on NAFLD/NASH based on the EASL 2009 special conference ☆

TL;DR: This poster presents a meta-modelling procedure called “spot-spot analysis” that allows for the direct comparison of the response of the immune system to various types of carbohydrates and its role in disease.
Journal ArticleDOI

Role of Kupffer cells in host defense and liver disease.

TL;DR: Kupffer cells constitute 80–90% of the tissue macrophages present in the body, and are therefore constantly exposed to gut‐derived bacteria, microbial debris and bacterial endotoxins, known to activate macrophage.
Journal ArticleDOI

Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

TL;DR: The pathophysiology of VLDL biosynthesis and metabolism in the metabolic syndrome is reviewed and the relation between hepatic accumulation of lipids and insulin resistance is reviewed, and sources of fatty acids for liver fat and VLDl biosynthesis are reviewed.
References
More filters
Journal ArticleDOI

Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man

TL;DR: The correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Journal ArticleDOI

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

TL;DR: A WHO Consultation has taken place in parallel with a report by an American Diabetes Association Expert Committee to re‐examine diagnostic criteria and classification of diabetes mellitus and is hoped that the new classification will allow better classification of individuals and lead to fewer therapeutic misjudgements.
Journal ArticleDOI

Glucose clamp technique: a method for quantifying insulin secretion and resistance.

TL;DR: Methods for the quantification of beta-cell sensitivity to glucose (hyperglycemic clamp technique) and of tissue sensitivity to insulin (euglycemic insulin clamp technique] are described.
Journal ArticleDOI

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

TL;DR: A novel estimate of insulin sensitivity that is simple to calculate and provides a reasonable approximation of whole-body insulin sensitivity from the oral glucose tolerance test (OGTT).
Related Papers (5)